Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

TransMedics (TMDX) Change in Inventory (2018 - 2025)

Historic Change in Inventory for TransMedics (TMDX) over the last 8 years, with Q3 2025 value amounting to $6.9 million.

  • TransMedics' Change in Inventory rose 5142.61% to $6.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$3.0 million, marking a year-over-year decrease of 11509.74%. This contributed to the annual value of $8.4 million for FY2024, which is 7026.56% down from last year.
  • Per TransMedics' latest filing, its Change in Inventory stood at $6.9 million for Q3 2025, which was up 5142.61% from -$3.7 million recorded in Q2 2025.
  • In the past 5 years, TransMedics' Change in Inventory registered a high of $10.1 million during Q3 2023, and its lowest value of -$4.1 million during Q4 2024.
  • Moreover, its 5-year median value for Change in Inventory was $2.1 million (2021), whereas its average is $2.7 million.
  • As far as peak fluctuations go, TransMedics' Change in Inventory soared by 66797.9% in 2022, and later plummeted by 26015.52% in 2025.
  • TransMedics' Change in Inventory (Quarter) stood at $930000.0 in 2021, then soared by 107.53% to $1.9 million in 2022, then skyrocketed by 265.96% to $7.1 million in 2023, then crashed by 158.57% to -$4.1 million in 2024, then surged by 266.84% to $6.9 million in 2025.
  • Its Change in Inventory was $6.9 million in Q3 2025, compared to -$3.7 million in Q2 2025 and -$2.0 million in Q1 2025.